How Protein C Deficiency is Diagnosed

Diagnosing Protein C deficiency is more complex than a simple “yes” or “no” blood test. Because Protein C levels naturally fluctuate based on your health and the medications you take, a single low reading is rarely enough to confirm you have a lifelong genetic condition ^[1][2]. Doctors must carefully time these tests to avoid results that look like an inherited deficiency but are actually caused by temporary or acquired factors.

The Two Main Ways to Measure Protein C

There are two primary types of functional tests used to see how your Protein C is working. The performance and interference of these tests vary by platform, laboratory, and your anticoagulant exposure, so the laboratory must select and interpret the method:

• Chromogenic Activity Assay: This is often the preferred first step because it generally has good specificity ^[3]. It measures how well Protein C can break down a specific chemical in a lab setting. It can occasionally miss rare types of the deficiency (specifically Type IIb) where the protein looks normal in this specific test but fails to work in the body ^[4][1].
• Clot-Based Activity Assay: This test mimics the actual clotting process in your blood. While it can detect some deficiencies that chromogenic testing might miss, it is much less specific ^[3]. This means it is very prone to interference from other factors ^[4].

Classifying the Deficiency: The Antigen Test

If your activity test comes back low, your doctor may order a Protein C Antigen test. This doesn’t measure how well the protein works; it simply counts how many Protein C molecules are in your blood ^[5].

• Type I (Quantitative): Both the activity level and the antigen count are low. Your body isn’t making enough of the protein ^[1].
• Type II (Qualitative): Your activity level is low, but your antigen count is normal. Your body makes enough protein, but the molecules are “broken” and don’t work correctly ^[6][1].

Critical Timing Pitfalls

Several situations can cause an “acquired” deficiency, where your Protein C levels are low temporarily. Testing during these times can lead to a misinterpretation:

1. The “Acute Clot” Phase: Acute thrombosis, inflammation, severe illness, and treatment can make results unreliable for several reasons. Testing during an active DVT or PE can show an acquired low result ^[2][7].
2. Warfarin (Coumadin): Protein C requires Vitamin K to be produced by the liver. Since Warfarin works by blocking Vitamin K, it physiologically lowers your Protein C levels. Functional protein C levels are unreliable while taking warfarin ^[1][2].
3. Liver Disease: Since Protein C is made in the liver, any condition that impairs liver function (like cirrhosis or hepatitis) can lead to low levels ^[1].

The DOAC Interference Problem

If you are taking a Direct Oral Anticoagulant (DOAC)—such as apixaban (Eliquis) or rivaroxaban (Xarelto)—it can interfere with testing. DOAC effects are drug- and assay-specific. They can falsely raise the measured Protein C level in clot-based assays, making it look like you have a healthy amount when you actually have a deficiency ^[1][3].

CRITICAL RULE: You must NEVER stop taking warfarin or a DOAC on your own simply to obtain a blood test. If retesting is needed, your treating clinician and laboratory will arrange it when it is clinically safe.

When is Genetic Testing Necessary?

While blood activity tests are the standard starting point, PROC gene sequencing (looking directly at your DNA) is used in specific cases:

• When blood test results are borderline or confusing ^[4].
• To confirm a diagnosis when “acquired” factors (like liver disease) make blood tests unreliable.
• To screen family members if a specific pathogenic variant has already been identified in the family ^[8].

However, genetic testing does not always provide a definitive answer. It may find a “variant of uncertain significance” (which does not establish the diagnosis), or a negative panel might miss certain variant types. Furthermore, genotype alone does not predict whether or when a person will clot. Genetic counseling is highly recommended to interpret these complex results ^[4][9].